You can narrow down the results using the filters
-
Investigating whether environmental factors such as air quality, pollen and socio-economic indices play affect the risk of perioperative respiratory adverse events in children
Expand descriptionPerioperative respiratory adverse events (PRAE) are significant causes of morbidity and mortality in paediatric anaesthesia and represent a significant burden on resource allocation and utilisation in perioperative areas. Environmental factors are likely to significantly influence the risk of PRAE. Exposure to high levels of air pollution or pollen is likely to trigger airway symptoms in patients with existing airway sensitivity and reactivity, making them more likely to experience laryngospasm, bronchospasm and airway obstruction. Socioeconomic indices may also be meaningfully linked to risk of PRAE through intermediatory variables including diet and nutrition, poor health literacy and barriers to timely access to healthcare. We propose a study to examine how the risk of PRAE is influenced by such environmental exposures, this will allow anaesthetic management for at-risk paediatric patients to be appropriately planned and executed. This study will generate insight into how the changing social and environmental conditions might impact children’s health outcomes. Two substudies will aim to: (1) compare data collected in 2022 and 2024 to data collected in 2007 and 2008 to investigate changes in anaesthetic management over time; and (2) to generate a novel predictive tool to appraise the risk of PRAE in children undergoing anaesthesia, and then internally validate the model by comparing performance to previously exist risk stratification tools, and externally validate the data by invesitgating its predictive ability in new data collected in 2025.
-
MELODY Trial: A 12-week randomised controlled trial of adjunctive melatonin or digital cognitive behavioural therapy for insomnia, or placebo to improve depressive symptoms in young adults with mood disorders
Expand descriptionMelatonin is considered safe, cost-effective, and scalable, thus, a justifiable intervention for circadian mood disorders. To counter the previous clinical trials design flaws, the present study will employ a larger sample size allowing for high statistical power of analyses. Additionally, in the proposed target treatment approach, patients will be stratified based on SCRDs (Sleep and Circadian Rhythm Disturbance) to enhance the potential effectiveness of the intervention. In a recent proof-of-concept study utilizing agomelatine, a melatonin agonist and serotonin antagonist, for the treatment of major depressive disorder, adults with depression had significantly reduced symptoms after the intervention (Robillard et al., 2018). Moreover, sleep disturbances were significantly reduced, and a strong correlation between relative improvements in depression severity and some components of circadian rhythm disturbances was reported (Robillard et al., 2018). The overall aim of the study is to examine whether melatonin is a more effective early intervention for youth with depression and SCRDs compared to dCBT-I alone. Additionally, the study aims to investigate whether improvements in SCRDs causally mediate changes in depressive symptoms. The outcomes of this clinical trial will hold significant implications for early intervention in mood disorders. The findings have the potential to validate and strengthen the hypothesis that individuals with circadian depression may respond more favourably to sleep and circadian-based interventions, such as melatonin. This, in turn, could have transformative implications for personalised interventions in the treatment of mood disorders.
-
Dietary and lifestyle predictors of pouchitis
Expand descriptionPouchitis is the most common inflammatory condition for those living with an ileoanal pouch (whereby the large bowel is removed due to medically unresponsive ulcerative colitis (UC) or familial adenomatous polyposis (FAP) and its cause is largely unknown. We aim to assess whether specific diet components and psychological factors such as stress can predict pouchitis. We also aim to assess whether faecal calprotectin (a marker of inflammation found in faeces) can be used as a test to predict worsening in pouch function or pouchitis. This study will follow patients with an ileoanal pouch prospectively for 18 months to evaluate if diet, stress and faecal calprotectin play a role in predicting pouchitis or worsening of pouchitis. This is important because there are currently no dietary guidelines to help ileoanal pouch patients.
-
Application of the fluorescent dye 'indocyanine green': Does it improve the quality of surgery for patients with oesophageal and stomach cancer?
Expand descriptionThis study will assess the use of a dye (indocyanine green or ICG) to identify lymph nodes within the oesophagus and stomach during surgery to remove lymph nodes in patients with stomach and/or oesophageal cancer. Who is it for? You may be eligible for this study if you are aged 18 years or older, you have been diagnosed with oesophagus, gastro-oesophageal junction and/or stomach cancer and you will be undergoing surgery as the primary treatment for your cancer. Study details All participants who choose to enrol in this study will have an additional step of a dye injection (ICG) at the start of surgery. The planned surgery will then be conducted as per usual process with as many lymph nodes removed as are identified. At the end of the surgery, the surgeon will then use a near-infrared camera to scan the tissue to identify and remove any additional lymph nodes containing ICG in the surgical field. It is hoped this research will determine whether a greater number of lymph nodes can be identified and removed with the ICG dye and camera scanning compared to usual care. If this method is found to be more successful at identifying and removing lymph nodes for patients with oesophageal and stomach cancers, it may be included in the usual care practices to improve outcomes for future cancer patients.
-
The acute effects of capsaicin on metabolism and thermogenesis in healthy adult females – a clinical trial
Expand descriptionStudies have shown that capsaicin may possibly be effective against weight gain and fat accumulation by inhibiting fat absorption and activating fat metabolism in the liver. Previous studies have demonstrated that it stimulates lipolysis, energy expenditure and thermogenesis. There is evidence that capsaicin stimulates resting energy expenditure, lipid mobilization and fat oxidation. It has also been found that ingestion after a glucose load promotes glucose consumption in young healthy males. This study will determine if the same effects are seen in young healthy females over the course of a normal oestrous cycle. The results of this study will then allow for translation to a pre-diabetic population to use capsaicin to augment diet and exercise to manage weight loss.
-
A weekend intervention for families with screen disordered children
Expand descriptionApproval was granted to run trials of a 3 day weekend intervention for children and parents in families where one child is screen disordered. This application was carefully scrutinised by the HREC, a separate meeting was organised to discuss more sensitive issues, and all ethical aspects were carefully addressed to HREC satisfaction before final approval was given. The trial will be run through Macquarie University, and the first trial will be filmed and paid for by Channel 7 for their Spotlight program. Prospective participants are given two information and consent forms - one from Macquarie and one from Channel 7 - and will speak to Channel 7 at length before making a decision to apply to participate, as we believe it is crucial participants are fully informed about the implications of the trial being televised before agreeing to participate. Final vetting of applications are by Prof Warburton and Mr Marshall, with the key criterion being no reasonably identifiable indication of potential harm to participants and an assessed likelihood that the child will benefit from the program.. Participants are fully informed and not coerced in any way to participate. Prof Warburton and Mr Marshall are not paid to create or run the program and have no conflicts of interest. It is hypothesised that child participants in the intervention will show reduced screen disorder symptoms and greater insight into their screen use immediately after the intervention, with continued benefits at 3 months after the program. It is also hypothesised that parents will report feeling more able to manage screen use issues in the home post intervention and will report improvements in their child's screen habits and symptoms 3 months after the program.
-
Investigating the effect of HypnoBirthing on epidural use during labour and birth
Expand descriptionThis study will adopt a multi methods approach to assess the effect of the HypnoBirthing program (Mongan Method) on analgesia use during labour and the birth experience. Data sources will consist of routinely collected clinical data from perinatal datasets, validated psychometric surveys, questionnaires and individual participant interviews. Clinical outcomes will be compared to a control population of birthing women using propensity matching of demographic, clinical and potentially confounding variables.
-
Noninvasive vagal nerve stimulation for abdominal symptoms in people with spinal cord injury
Expand descriptionThis pilot study will examine the efficacy of transcutaneous (non-invasive) vagal nerve stimulation in people with spinal cord injury. Many people with spinal cord injury suffer from abdominal pain and gastrointestinal symptoms that do not respond to treatment target usual pain receptors. It has been postulated that these symptoms are mediated by the vagus nerve. Modulating the vagus nerve by transcutaneous stimulation may provide relief from these symptoms. Efficacy will be examined by patient-reported pain scores, pain maps, as gastrointestinal motility study.
-
Effects of Exclusive Enteral Nutrition (EEN) with fibre in healthy participants
Expand descriptionExclusive Enteral Nutrition (EEN) reduces inflammation and allows complete gut healing in up to 80% of people with Crohn’s Disease (CD). EEN involves removing all food and replacing it with a liquid containing all essential nutrients for 6-8 weeks. This treatment is superior to steroids in treating inflammation and is being increasingly used across Australasia as first-line therapy, particularly in children. Despite EEN having been shown to be effective in numerous studies, the ways in which it works to reduce inflammation is still unknown and this study seeks to address the hypotheses by assessing how EEN works. The best way to assess how a therapy works to treat disease is to examine its impact in a 'normal' gut with limited confounders.
-
Comparison of demographics, clinical symptoms, and urodynamic findings between detrusor overactivity with detrusor underactivity patients under the age of 70 and those aged 70 or older
Expand descriptionDetrusor overactivity with detrusor underactivity (DO-DU) is classically described in frail institutionalized elderly patients, but we have also observed this diagnosis in younger populations. This research attempts to retrospectively compare demographic characteristics, clinical presentations, and urodynamic findings between two age groups of DO-DU patients: those younger than 70 years and those aged 70 years or older. Our hypothesis predicts that the younger group would exhibit a higher prevalence of risk factors in their demographic data, while the elderly group will demonstrate a greater incidence of urgency and urge incontinence, likely attributed to limited mobility. Additionally, the urodynamic findings are expected to reveal less bladder contraction in the elderly group, which can be attributed to the effects of advanced age.